Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of August 10, 2026.

Siddharth Kumar Iyengar, MD

Individual provider Internal Medicine Physician · NPI 1003376187

Siddharth Kumar Iyengar, MD practises Hematology/Oncology in San Diego, California. Graduated from University of Miami, Lm Miller School of Medicine in 2019, 7 years ago. Practices with House Medicine, a 9-clinician group, works from 4 locations and accepts Medicare assignment. Licensed in California and Utah.

Years since qualifying
7
Trained at
University of Miami, Lm Miller School of Medicine
Licensed in
CA, UT
In the registry since
2019
Specialties on file
2
What do these letters mean?
MD — Doctor of Medicine
A physician who completed allopathic medical school.

See every abbreviation used in this directory →

Practice location Address checks out

200 W Arbor Dr
San Diego, CA 92103-9000
Phone: (800) 926-8273
Fax: (888) 539-8781
Show map & directions

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Additional practice locations (3)

  • 1200 Garden View Rd, Encinitas, CA 92024-2477 — (800) 926-8273
  • 910 Sycamore Ave Ste 102, Vista, CA 92081-7833 — (800) 926-8273
  • 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132-0002 — (801) 581-7606

Specialties & licences

Medical Oncology Physician (primary) Taxonomy 207RX0202X · Licence 181976 (CA)
Internal Medicine Physician Taxonomy 207R00000X · Licence 11901347-1205 (UT)

Record details

NPI number1003376187
Entity typeIndividual (Type 1)
GenderMale
Credentials MD
Sole proprietorNo
NPI enumeratedMarch 23, 2019
Last updated in NPPESAugust 4, 2026
Certification dateAugust 4, 2026

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyHEMATOLOGY/ONCOLOGY
Also practisesINTERNAL MEDICINE
Medical schoolUNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduated 2019 (7 years in practice)
Group practice House Medicine — 9 clinicians
Accepts Medicare assignment Yes — accepts the Medicare-approved amount

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $630 19 payments · a meal or drink at a meeting or visit, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Colleagues at House Medicine

Clinicians the CMS Doctors & Clinicians file lists under the same group practice.

Other providers in San Diego